Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study (Q44405259)

2 December 2017

title

Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study (English)

1 reference

2 December 2017

Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

24 December 2023

1 reference

lymphoblastic leukemia

1 reference

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

24 December 2023

author name string

Arnold Altman

3

1 reference

2 December 2017

Harland Sather

4

1 reference

2 December 2017

Suresh Jhanwar

5

1 reference

2 December 2017

Steven Halpern

6

1 reference

2 December 2017

Richard Pieters

7

1 reference

2 December 2017

Narayan Shah

8

1 reference

2 December 2017

Laurel Steinherz

9

1 reference

2 December 2017

Raymond Tannous

10

1 reference

2 December 2017

William Terry

11

1 reference

2 December 2017

Children's Cancer Group

13

1 reference

2 December 2017

John A. Heath

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697887

24 December 2023

Peter G. Steinherz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697887

24 December 2023

Michael E. Trigg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697887

24 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

15 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12697887

full work available at URL

24 December 2023

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.07.129

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Journal of Clinical Oncology

24 December 2023

published in

1 reference

2 December 2017

volume

21

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1612-1617

1 reference

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

24 December 2023

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia

24 December 2023

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study

24 December 2023

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia

24 December 2023

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia

24 December 2023

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group

24 December 2023

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol

24 December 2023

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure

24 December 2023

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group

24 December 2023

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL

24 December 2023

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children

24 December 2023

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen

24 December 2023

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials

24 December 2023

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients

24 December 2023

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial.

24 December 2023

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.129

24 December 2023

Identifiers

1 reference

2 December 2017

1 reference